All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F21%3A00551988" target="_blank" >RIV/61388963:_____/21:00551988 - isvavai.cz</a>

  • Result on the web

    <a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20211221&DB=&locale=en_EP&CC=US&NR=11203610B2&KC=B2&ND=5" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20211221&DB=&locale=en_EP&CC=US&NR=11203610B2&KC=B2&ND=5</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein

  • Original language description

    The present disclosure relates to 2′3′ cyclic phosphonate dinucleotides of general formula (J), their pharmaceutically acceptable salts, their pharmaceutical composition and combinations of said substances and other medicaments or pharmaceuticals. The disclosure also relates to the use of said compounds for the treatment or prevention of diseases or conditions modifiable by STING protein modulation, such as cancer or viral, allergic and inflammatory diseases. In addition, these substances can be used as adjuvants in vaccines.

  • Czech name

  • Czech description

Classification

  • Type

    P - Patent

  • CEP classification

  • OECD FORD branch

    10401 - Organic chemistry

Result continuities

  • Project

    <a href="/en/project/EF16_019%2F0000729" target="_blank" >EF16_019/0000729: Chemical biology for drugging undruggable targets</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Patent/design ID

    US11203610

  • Publisher

    US001 -

  • Publisher name

    United States Patent and Trademark Office (USPTO)

  • Place of publication

    Alexandria

  • Publication country

    US - UNITED STATES

  • Date of acceptance

    Dec 21, 2021

  • Owner name

    Ústav organické chemie a biochemie AV ČR, v. v. i

  • Method of use

    A - Výsledek využívá pouze poskytovatel

  • Usage type

    A - K využití výsledku jiným subjektem je vždy nutné nabytí licence